MASLD Journal Updates Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease Topiramate treatment of pediatric metabolic dysfunction-associated steatotic liver disease: A descriptive cohort study Exploring non-invasive diagnostics and non-imaging approaches for pediatric metabolic dysfunction-associated steatotic liver disease Exploring non-invasive diagnostics and non-imaging approaches for pediatric metabolic dysfunction-associated steatotic liver disease FISPGHAN statement on the global public health impact of metabolic dysfunction-associated steatotic liver disease Strategic interventions in clinical randomized trials for metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity in the pediatric population: a systematic review with meta-analysis and bibliometric analysis Pediatric MASLD: current understanding and practical approach Anne-Sophie R Stroes 1, Miriam Vos 2, Marc A Benninga 1, Bart G P Koot 3 Abstract Pharmacological management of pediatric metabolic dysfunction-associated steatotic liver disease Cotinine exposure enhances the association of blood manganese and non-alcoholic fatty liver disease in American children: a cross-sectional study The association of fructose and fiber consumption and physical activity with non-alcoholic fatty liver disease in children and adolescents: a cross-sectional study Cotinine exposure enhances the association of blood manganese and non-alcoholic fatty liver disease in American children: a cross-sectional study Irisin as a marker of hepatic steatosis in children with metabolic dysfunction-associated steatotic liver disease Adipokine/hepatokines profiling of fatty liver in adolescents and young adults: cross-sectional and prospective analyses of the BCAMS study Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial Comparing body composition measures in children with end stage liver disease using noninvasive bioimpedance analysis Reduced insulin clearance in paediatric metabolic (dysfunction)-associated fatty liver disease and its dual role in beta-cell offload and diabetes risk Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial Reduced insulin clearance in paediatric metabolic (dysfunction)-associated fatty liver disease and its dual role in beta-cell offload and diabetes risk Development and validation of pFIB scores for exclusion of significant liver fibrosis in pediatric MASLD
